UNSPSC 51144801: Etamivan or ethamivan

This classification denotes a cns stimulant with the molecular formula C12H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M44O63YPV9, chemically known as vanillic acid n,n-diethylamide but more generally known as etamivan, which bears US NIH Compound Identifier 9363. European Medicines Agency schedules Etamivan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07259MIG.

UNSPSC 51144801 Etamivan or ethamivan is a Commodity code that in practice captures state and local procurement of pharmaceutical products and related health-support supplies, including respiratory stimulants, naloxone (opioid antagonists), drug deactivation systems, and generic multi-source pharmaceuticals for distribution through state and local health, community health, and pharmacy benefit programs. State and local issuing bodies soliciting under this code include county health departments, state health and human services commissions, and cooperative purchasing alliances serving multiple state and local jurisdictions. The work involves competitive bidding for supply of pharmaceutical inventory, often with quarterly or regular deliveries to designated health facilities, compliance with federal manufacturing and supply-chain security standards, and pricing structured through wholesaler networks and administrative fee models.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building and a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted Request for Information HHS0017013 on April 3, 2026 to gather vendor capability data on direct-to-manufacturer prescription programs and therapeutic pharmacy initiatives, with no formal award timeline specified at the RFI stage. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and over-the-counter products with a response deadline of March 26, 2026, requiring vendors to maintain relationships with three authorized wholesalers and supply products through cooperative arrangements extending to Oregon and other participating jurisdictions, with contract effectiveness set for July 1, 2026.